Bahamas vs Democratic Republic of Congo: Access to anti-retroviral drugs, male (%)
Bahamas
74.0%
in 2024
Democratic Republic of Congo
75.0%
in 2024
Bahamas rank
58th
Democratic Republic of Congo rank
55th
Access to anti-retroviral drugs, male (%) over time
- Bahamas
- Democratic Republic of Congo
How they compare
Democratic Republic of Congo currently reports 75.0% against 74.0% in Bahamas, a difference of 1.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Democratic Republic of Congo ahead.
Bahamas ranks 58th and Democratic Republic of Congo ranks 55th of 141 countries.
Bahamas has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahamas | Democratic Republic of Congo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.9% | 1.9% | 15.0% | Bahamas |
| 2010s | 47.5% | 19.5% | 28.0% | Bahamas |
| 2020s | 71.8% | 68.0% | 3.8% | Bahamas |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Bahamas or Democratic Republic of Congo?
- Democratic Republic of Congo, at 75.0% against 74.0% in Bahamas as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Bahamas and Democratic Republic of Congo?
- 1.0%, with Democratic Republic of Congo ahead.
- How many years of comparable data are there for Bahamas and Democratic Republic of Congo?
- 25 years are reported by both, from 2000 to 2024.
- How do Bahamas and Democratic Republic of Congo rank globally for access to anti-retroviral drugs, male?
- Bahamas ranks 58th and Democratic Republic of Congo ranks 55th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.